[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100424283":3},{"organization":4,"armGroups":7,"interventions":15,"overallOfficials":27,"centralContacts":31,"locations":37,"responsibleParty":55,"collaborators":10,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":64,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":68,"maxAge":10,"enrollmentInfo":69,"targetDuration":72,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":10,"overallStatus":39,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"Morehouse School of Medicine","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Biospeciman Repository and Data Collection",null,"Patients with cancer or who are at risk of having cancer who have given consent to have blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) collected and stored for the advancement of medicine.",[13,14],"Procedure: Collection of blood, tissue, and other biological samples.","Other: Medical Chart Review",[16,23],{"type":17,"name":18,"description":19,"armGroupLabels":20,"otherNames":21},"PROCEDURE","Collection of blood, tissue, and other biological samples.","Behavioral health assessments, including quality of life.",[9],[22],"Surveys",{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":10},"Medical Chart Review","Health data abstracted directly from patient's health records",[9],[28],{"name":29,"affiliation":5,"role":30},"James W Lillard, PhD","PRINCIPAL_INVESTIGATOR",[32],{"name":33,"role":34,"phone":35,"phoneExt":10,"email":36},"LaTrisha Horne","CONTACT","404-752-1034","totalcancercare@msm.edu",[38],{"facility":5,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"RECRUITING","Atlanta","Georgia","30310","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-84.38798,33.749,{"lat":49,"lon":48},[52],{"name":53,"role":34,"phone":35,"phoneExt":10,"email":54},"Margaret Hooker","mhooker@msm.edu",{"type":30,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"James Lillard, PhD","Professor of Microbiology, Biochemistry, & Immunology","100424283","morehouse-total-cancer-care-protocol-100424283",false,"NCT04804878","Morehouse Total Cancer Care Protocol","Morehouse Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer","MSMTCC","Inclusion Criteria:\n\n1. 18 years of age and older.\n2. Diagnosed with cancer, or at risk for cancer. This includes anyone in the general population, but our primary focus will be on patients with a cancer diagnosis.\n3. Able to understand and sign the TCCP Informed Consent and Research Authorization form directly or through an authorized representative. The Informed Consent and Research Authorization will be available in both English and Spanish languages\n\nExclusion Criteria:\n\nNone\n\n\\-",true,"ALL","18 Years",{"count":70,"type":71},5000,"ESTIMATED","5 Years","OBSERVATIONAL","The overall objective of the Morehouse Total Cancer Care study is to develop an improved standard of cancer care by facilitating new biomarker and drug target discovery, informatics solutions, clinical trials, and \"personalized medicine\" for our community oncology partners (i.e., community hospital systems, and other cancer care providers). To bring new translational research to the community, Morehouse School of Medicine has initiated the Total Cancer Care Program (TCCP). The TCCP establishes a unique collection of blood, tissue, other biological samples and their associated data (survey data, medical records data, cancer registry data, and other related data) from thousands of African American cancer patients, survivors, or those at risk of having cancer. This is not a treatment trial, but a longitudinal study designed to create a centralized cancer biorepository for precision medicine.",[76,77],"Cancer","Cancer Risk","2021-03-16",{"date":80,"type":81},"2021-03-18","ACTUAL",{"date":83,"type":81},"2018-04-05",{"date":85,"type":71},"2037-04",{"name":5,"class":6},1]